Building a Medicinal Chemistry Framework for Bioorthogonal Probes.
Markus Staudt1,2,3, Jonathan C T Carlson1,4
1Center for Systems Biology, Massachusetts General Hospital Research Institute, Boston, Massachusetts 02114, United States.
ACS Central Science
|July 3, 2025
Summary
Screening the tetrazine-protein interactome identified key factors for developing high-performance fluorescent probes. This research balances molecular interactions for improved probe design and application.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Imaging
Background:
- Tetrazine-based bioorthogonal chemistry is crucial for biological research.
- Developing fluorescent probes requires understanding molecular interactions.
- Optimizing probe performance necessitates a balanced approach to molecular design.
More Related Videos
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013
10.9K
16:16Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
Published on: September 13, 2013
15.4K
Related Concept Videos
03:31Labeling DNA Probes
8.4K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.4K
01:26Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K